<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03127228</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00124386</org_study_id>
    <nct_id>NCT03127228</nct_id>
  </id_info>
  <brief_title>Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis</brief_title>
  <official_title>Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Morita J USA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate if using Erbium-doped yttrium aluminium garnet laser,
      Erbium YAG laser (Er:YAG) laser could have adjunctive benefits to the conventional standard
      mechanical debridement to ablate the infected tissue around the dental implant and detoxify
      the contaminated implant surface for resolving peri-implant infection and enhance bone
      regeneration of peri-implant defects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to evaluate if using Er:YAG laser could have adjunctive benefits
      to the conventional standard mechanical debridement to ablate the infected tissue around the
      dental implant and detoxify the contaminated implant surface for resolving peri-implant
      infection and enhance bone regeneration of peri-implant defects.

      This study involves one center and a double-blinded randomized controlled clinical trial is
      planned. Twenty-four adult patients in the need of surgical treatment due to peri-implantitis
      will be included. Six visits are needed for each patient including a 24 week follow-up visit.

      Specific Aim 1: To compare the clinical benefit of Er:YAG laser-assisted peri-implant defect
      debridement and surface detoxification with conventional mechanical debridement for
      regenerative therapy

      Specific Aim 2: To evaluate whether Er:YAG laser-assisted regenerative surgical therapy can
      decrease bacterial load and alter microbial profile

      Specific Aim 3: To analyze whether Er:YAG laser-assisted regenerative surgical therapy can
      impact the molecular profile of the peri-implant crevicular fluid (PICF) and the stability of
      the treatment
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 26, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Periodontal Probing Depths (PD)</measure>
    <time_frame>Three years</time_frame>
    <description>PD will be measured in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Attachment Level (CAL)</measure>
    <time_frame>Three years</time_frame>
    <description>CAL will be measured in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gingival Index (GI)</measure>
    <time_frame>Three years</time_frame>
    <description>GI will be measured by a score of 0,1,2,3 Score 0: Normal Gingiva Score 1: Mild inflammation, slight change in color, slight edema, no bleeding on probing.
Score 2: Moderate inflammation, redness, edema, glazing, bleeding on probing. Score 3: Severe inflammation, marked redness, edema, ulceration and tendency to spontaneous bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding on Probing (BOP)</measure>
    <time_frame>Three years</time_frame>
    <description>BOP will be measured dichotomously as 0 or 1. Score 0=no. Score 1=yes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic bone fill (RBF)</measure>
    <time_frame>Three years</time_frame>
    <description>Peri-implant bony defect change will be measured compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op pain Assessment</measure>
    <time_frame>Three years</time_frame>
    <description>Post-op pain assessment will be measured on a 11 points Numeric Rating Scale (11-NRS). The scale range is 0-10 with zero equal to no pain and 10 equal to serve pain.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Peri-implant crevicular fluid (PICF) microbiological and biomarker analysis</measure>
    <time_frame>Three years</time_frame>
    <description>Bacterial and biomarker profiles will be assessed at selected time points</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Standard mechanical debridement</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with dental scalers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Er:YAG laser-assisted debridement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Debridement and surface detoxification of the implant surface and removal of the inflamed tissue with the aid of the laser treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard mechanical debridement</intervention_name>
    <description>Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with dental scalers prior to bone grafting regenerative therapy</description>
    <arm_group_label>Standard mechanical debridement</arm_group_label>
    <arm_group_label>Er:YAG laser-assisted debridement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Er:YAG laser-assisted debridement</intervention_name>
    <description>Implantoplasty will be performed for peri-implant suprabony defect and infrabony defect will be debrided with the aid of the laser prior to bone grafting regenerative therapy</description>
    <arm_group_label>Er:YAG laser-assisted debridement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects, aged 18 - 85 years

          -  Physical status according to the American Society of Anesthesiologists (ASA) I or II,
             which includes patients who are systemically healthy or suffer under mild to moderate,
             but well controlled systemic diseases.

          -  Subjects having a minimum of 1 dental implant with peri-implantitis.

          -  Dental implants with peri-implantitis ≥ 2 threads exposed (infrabony defect)
             identified on the radiograph and pocket probing depth (PPD) ≥ 5mm, with bleeding on
             probing (BOP) and/or suppuration (pus)

          -  The implants are in function for at least 6 months

          -  Only rough surface implant will be included in this study

        Exclusion Criteria:

          -  Long-term use of antibiotics &gt; 2 weeks in the past two months

          -  Obvious malpositioning of the dental implants

          -  Subjects taking medications known to modify bone metabolism (such as bisphosphonates,
             corticosteroids, Hormone replacement therapy for menopausal women, parathyroid
             hormone, Denosumab, strontium ranelate)

          -  Pregnant females or those planning to become pregnant

          -  Subjects with a history of major diseases, oral cancer, sepsis or those having adverse
             outcomes to oral procedures in the past, will be excluded

          -  Mobility of dental implants

          -  History of alcoholism or drug abuse

          -  Current smokers

          -  Diseases of the immune system or any medical condition that may influence the outcome
             (uncontrolled diabetes (HbA1c &gt;8)

          -  Uncontrolled systemic disease or condition known to alter bone metabolism, like
             Osteoporosis, Osteopenia, Hyperparathyroidism, Paget's disease

        Premature Exclusion Criteria:

          -  The researcher believes that it is not the best interest of the subject to stay in the
             study

          -  If the subject becomes ineligible to participate based on the exclusion criteria

          -  If the subject's medical condition requires interventions which preclude involvement
             in the study (radiation therapy, chemotherapy, etc)

          -  If the subject does not follow study related instructions

          -  The study is suspended or canceled.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff (Chin-Wei) Wang, DDS, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Periodontics and Oral Medicine University of Michigan School of Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan School of Dentistry</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aljateeli M, Fu JH, Wang HL. Managing peri-implant bone loss: current understanding. Clin Implant Dent Relat Res. 2012 May;14 Suppl 1:e109-18. doi: 10.1111/j.1708-8208.2011.00387.x. Epub 2011 Oct 10. Review.</citation>
    <PMID>21985674</PMID>
  </reference>
  <reference>
    <citation>Aoki A, Mizutani K, Schwarz F, Sculean A, Yukna RA, Takasaki AA, Romanos GE, Taniguchi Y, Sasaki KM, Zeredo JL, Koshy G, Coluzzi DJ, White JM, Abiko Y, Ishikawa I, Izumi Y. Periodontal and peri-implant wound healing following laser therapy. Periodontol 2000. 2015 Jun;68(1):217-69. doi: 10.1111/prd.12080.</citation>
    <PMID>25867988</PMID>
  </reference>
  <reference>
    <citation>Atieh MA, Alsabeeha NH, Faggion CM Jr, Duncan WJ. The frequency of peri-implant diseases: a systematic review and meta-analysis. J Periodontol. 2013 Nov;84(11):1586-98. doi: 10.1902/jop.2012.120592. Epub 2012 Dec 13. Review.</citation>
    <PMID>23237585</PMID>
  </reference>
  <reference>
    <citation>Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontol. 2008 Sep;35(8 Suppl):316-32. doi: 10.1111/j.1600-051X.2008.01277.x. Review.</citation>
    <PMID>18724859</PMID>
  </reference>
  <reference>
    <citation>De Bruyn H, Vandeweghe S, Ruyffelaert C, Cosyn J, Sennerby L. Radiographic evaluation of modern oral implants with emphasis on crestal bone level and relevance to peri-implant health. Periodontol 2000. 2013 Jun;62(1):256-70. doi: 10.1111/prd.12004. Review.</citation>
    <PMID>23574471</PMID>
  </reference>
  <reference>
    <citation>Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71. doi: 10.1111/jcpe.12334. Review.</citation>
    <PMID>25495683</PMID>
  </reference>
  <reference>
    <citation>Fransson C, Lekholm U, Jemt T, Berglundh T. Prevalence of subjects with progressive bone loss at implants. Clin Oral Implants Res. 2005 Aug;16(4):440-6.</citation>
    <PMID>16117768</PMID>
  </reference>
  <reference>
    <citation>Gonçalves F, Zanetti AL, Zanetti RV, Martelli FS, Avila-Campos MJ, Tomazinho LF, Granjeiro JM. Effectiveness of 980-mm diode and 1064-nm extra-long-pulse neodymium-doped yttrium aluminum garnet lasers in implant disinfection. Photomed Laser Surg. 2010 Apr;28(2):273-80. doi: 10.1089/pho.2009.2496.</citation>
    <PMID>19811080</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, Karoly P, O'Riordan EF, Bland F Jr, Burns RS. The subjective experience of acute pain. An assessment of the utility of 10 indices. Clin J Pain. 1989 Jun;5(2):153-9.</citation>
    <PMID>2520397</PMID>
  </reference>
  <reference>
    <citation>Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, Giannobile WV. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol. 2014 Feb;41(2):113-120. doi: 10.1111/jcpe.12194. Epub 2013 Dec 12.</citation>
    <PMID>24303954</PMID>
  </reference>
  <reference>
    <citation>Kreisler M, Kohnen W, Marinello C, Götz H, Duschner H, Jansen B, d'Hoedt B. Bactericidal effect of the Er:YAG laser on dental implant surfaces: an in vitro study. J Periodontol. 2002 Nov;73(11):1292-8.</citation>
    <PMID>12479633</PMID>
  </reference>
  <reference>
    <citation>Marrone A, Lasserre J, Bercy P, Brecx MC. Prevalence and risk factors for peri-implant disease in Belgian adults. Clin Oral Implants Res. 2013 Aug;24(8):934-40. doi: 10.1111/j.1600-0501.2012.02476.x. Epub 2012 May 3.</citation>
    <PMID>22551347</PMID>
  </reference>
  <reference>
    <citation>Matys J, Dominiak M. Assessment of Pain When Uncovering Implants with Er:YAG Laser or Scalpel for Second Stage Surgery. Adv Clin Exp Med. 2016 Nov-Dec;25(6):1179-1184. doi: 10.17219/acem/62456.</citation>
    <PMID>28028971</PMID>
  </reference>
  <reference>
    <citation>Nevins M, Nevins ML, Yamamoto A, Yoshino T, Ono Y, Wang CW, Kim DM. Use of Er:YAG laser to decontaminate infected dental implant surface in preparation for reestablishment of bone-to-implant contact. Int J Periodontics Restorative Dent. 2014 Jul-Aug;34(4):461-6. doi: 10.11607/prd.2192.</citation>
    <PMID>25006763</PMID>
  </reference>
  <reference>
    <citation>Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol. 2013 Apr;84(4):436-43. doi: 10.1902/jop.2013.134001. Review.</citation>
    <PMID>23537178</PMID>
  </reference>
  <reference>
    <citation>Quaranta A, Maida C, Scrascia A, Campus G, Quaranta M. Er:Yag Laser application on titanium implant surfaces contaminated by Porphyromonas gingivalis: an histomorphometric evaluation. Minerva Stomatol. 2009 Jul-Aug;58(7-8):317-30. English, Italian.</citation>
    <PMID>19633633</PMID>
  </reference>
  <reference>
    <citation>Renvert S, Roos-Jansåker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol. 2008 Sep;35(8 Suppl):305-15. doi: 10.1111/j.1600-051X.2008.01276.x. Review.</citation>
    <PMID>18724858</PMID>
  </reference>
  <reference>
    <citation>Schwarz F, Hegewald A, John G, Sahm N, Becker J. Four-year follow-up of combined surgical therapy of advanced peri-implantitis evaluating two methods of surface decontamination. J Clin Periodontol. 2013 Oct;40(10):962-7. doi: 10.1111/jcpe.12143. Epub 2013 Aug 12.</citation>
    <PMID>23931259</PMID>
  </reference>
  <reference>
    <citation>Schwarz F, Sahm N, Iglhaut G, Becker J. Impact of the method of surface debridement and decontamination on the clinical outcome following combined surgical therapy of peri-implantitis: a randomized controlled clinical study. J Clin Periodontol. 2011 Mar;38(3):276-84. doi: 10.1111/j.1600-051X.2010.01690.x. Epub 2011 Jan 11.</citation>
    <PMID>21219392</PMID>
  </reference>
  <reference>
    <citation>Suárez-López Del Amo F, Yu SH, Wang HL. Non-Surgical Therapy for Peri-Implant Diseases: a Systematic Review. J Oral Maxillofac Res. 2016 Sep 9;7(3):e13. eCollection 2016 Jul-Sep. Review.</citation>
    <PMID>27833738</PMID>
  </reference>
  <reference>
    <citation>Takasaki AA, Aoki A, Mizutani K, Kikuchi S, Oda S, Ishikawa I. Er:YAG laser therapy for peri-implant infection: a histological study. Lasers Med Sci. 2007 Sep;22(3):143-57. Epub 2007 Jan 12.</citation>
    <PMID>17219255</PMID>
  </reference>
  <reference>
    <citation>Wang HL, Garaicoa-Pazmino C, Collins A, Ong HS, Chudri R, Giannobile WV. Protein biomarkers and microbial profiles in peri-implantitis. Clin Oral Implants Res. 2016 Sep;27(9):1129-36. doi: 10.1111/clr.12708. Epub 2015 Oct 1.</citation>
    <PMID>26424287</PMID>
  </reference>
  <reference>
    <citation>Yamamoto A, Tanabe T. Treatment of peri-implantitis around TiUnite-surface implants using Er:YAG laser microexplosions. Int J Periodontics Restorative Dent. 2013 Jan-Feb;33(1):21-30.</citation>
    <PMID>23342343</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Chin-Wei Wang</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Laser</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

